{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:36:53Z","timestamp":1789663013055,"version":"4.0.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>A retrospective observational study was conducted to assess the prevalence of maturity onset diabetes of the young (MODY) in a large paediatric population of Southern Italy newly diagnosed with diabetes. Clinical and genetic features of the identified MODY patients were also described.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Genetic testing was performed in children and adolescents newly diagnosed with diabetes who presented autoantibody negativity and fasting C-peptide levels\u2009\u2265\u20090.8\u00a0ng\/mL. Patients with a low insulin daily dose and optimal glycaemic control after two years from diabetes onset were also investigated for monogenic diabetes, regardless of their autoimmunity status and\/or C-peptide levels.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A prevalence of 6.5% of MODY was found. In particular, glucokinase-MODY was the most common type of MODY. The mean age at diagnosis was 9.1\u00a0years. Clinical presentation and biochemical data were heterogeneous also among patients belonging to the same MODY group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>We found a relatively high prevalence of MODY among paediatric patients with a new diagnosis of diabetes in comparison to literature data. Our findings highlight that a more detailed clinical evaluation along with easier and less expensive approachability to genetic testing may allow diagnosing an increasing number of MODY cases. A correct, prompt diagnosis is crucial to choose the most appropriate treatment and offer adequate genetic counselling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13098-021-00716-6","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T08:03:03Z","timestamp":1631088183000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Clinical and genetic features of maturity-onset diabetes of the young in pediatric patients: a 12-year monocentric experience"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4369-7798","authenticated-orcid":false,"given":"Stefano","family":"Passanisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Salzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Bombaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,8]]},"reference":[{"issue":"3\u20134","key":"716_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1515\/jpem-2014-0384","volume":"28","author":"A An\u0131k","year":"2015","unstructured":"An\u0131k A, \u00c7atl\u0131 G, Abac\u0131 A, B\u00f6ber E. Maturity-onset diabetes of the young (MODY): an update. J Pediatr Endocrinol Metab. 2015;28(3\u20134):251\u201363. https:\/\/doi.org\/10.1515\/jpem-2014-0384.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"716_CR2","doi-asserted-by":"publisher","unstructured":"American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15-S33. https:\/\/doi.org\/10.2337\/dc21-S002","DOI":"10.2337\/dc21-S002"},{"issue":"12","key":"716_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s11892-018-1111-4","volume":"18","author":"S Misra","year":"2018","unstructured":"Misra S, Owen KR. Genetics of monogenic diabetes: present clinical challenges. Curr Diab Rep. 2018;18(12):141. https:\/\/doi.org\/10.1007\/s11892-018-1111-4.","journal-title":"Curr Diab Rep"},{"issue":"Suppl 27","key":"716_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/pedi.12772","volume":"19","author":"AT Hattersley","year":"2018","unstructured":"Hattersley AT, Greeley SAW, Polak M, et al. ISPAD Clinical Practice Consensus Guidelines 2018: the diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018;19(Suppl 27):47\u201363. https:\/\/doi.org\/10.1111\/pedi.12772.","journal-title":"Pediatr Diabetes"},{"key":"716_CR5","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.2147\/DMSO.S179793","volume":"12","author":"T Urakami","year":"2019","unstructured":"Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes. 2019;12:1047\u201356. https:\/\/doi.org\/10.2147\/DMSO.S179793.","journal-title":"Diabetes Metab Syndr Obes."},{"issue":"3","key":"716_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1007\/s00125-013-3119-2","volume":"57","author":"J Stanik","year":"2014","unstructured":"Stanik J, Dusatkova P, Cinek O, et al. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed. Diabetologia. 2014;57(3):480\u20134. https:\/\/doi.org\/10.1007\/s00125-013-3119-2.","journal-title":"Diabetologia"},{"issue":"7","key":"716_CR7","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1111\/pedi.12714","volume":"19","author":"T Yorifuji","year":"2018","unstructured":"Yorifuji T, Higuchi S, Kawakita R, Hosokawa Y, Aoyama T, Murakami A, Kawae Y, Hatake K, Nagasaka H, Tamagawa N. Genetic basis of early-onset, maturity-onset diabetes of the young-like diabetes in Japan and features of patients without mutations in the major MODY genes: Dominance of maternal inheritance. Pediatr Diabetes. 2018;19(7):1164\u201372. https:\/\/doi.org\/10.1111\/pedi.12714.","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"716_CR8","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1007\/s13300-019-0633-3","volume":"10","author":"G Salzano","year":"2019","unstructured":"Salzano G, Passanisi S, Mamm\u00ec C, Priolo M, Pintomalli L, Caminiti L, Messina MF, Pajno GB, Lombardo F. Maturity onset diabetes of the young is not necessarily associated with autosomal inheritance: case description of a de novo HFN1A mutation. Diabetes Ther. 2019;10(4):1543\u20138. https:\/\/doi.org\/10.1007\/s13300-019-0633-3.","journal-title":"Diabetes Ther"},{"issue":"6","key":"716_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.4093\/dmj.2015.39.6.468","volume":"39","author":"SH Kim","year":"2015","unstructured":"Kim SH. Maturity-onset diabetes of the young: what do clinicians need to know? Diabetes Metab J. 2015;39(6):468\u201377. https:\/\/doi.org\/10.4093\/dmj.2015.39.6.468.","journal-title":"Diabetes Metab J"},{"issue":"2","key":"716_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.2337\/dc13-1838","volume":"37","author":"DJ Pettitt","year":"2014","unstructured":"Pettitt DJ, Talton J, Dabelea D, et al. Prevalence of diabetes in U.S. youth in 2009: the SEARCH for diabetes in youth study. Diabetes Care. 2014;37(2):402\u20138. https:\/\/doi.org\/10.2337\/dc13-1838.","journal-title":"Diabetes Care"},{"issue":"3","key":"716_CR11","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.diabres.2015.01.003","volume":"107","author":"E Mozzillo","year":"2015","unstructured":"Mozzillo E, Salzano G, Barbetti F, Maffeis C, Lombardo F, Franzese A, Delvecchio M, Marigliano M. Survey on etiological diagnosis of diabetes in 1244 Italian diabetic children and adolescents: impact of access to genetic testing. Diabetes Res Clin Pract. 2015;107(3):e15\u20138. https:\/\/doi.org\/10.1016\/j.diabres.2015.01.003.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"716_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s00125-016-4167-1","volume":"60","author":"BB Johansson","year":"2017","unstructured":"Johansson BB, Irgens HU, Molnes J, et al. Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry. Diabetologia. 2017;60(4):625\u201335. https:\/\/doi.org\/10.1007\/s00125-016-4167-1.","journal-title":"Diabetologia"},{"issue":"10","key":"716_CR13","doi-asserted-by":"publisher","first-page":"4055","DOI":"10.1210\/jc.2013-1279","volume":"98","author":"C Pihoker","year":"2013","unstructured":"Pihoker C, Gilliam LK, Ellard S, et al. Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013;98(10):4055\u201362. https:\/\/doi.org\/10.1210\/jc.2013-1279.","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 5","key":"716_CR14","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1177\/0004563213483458","volume":"50","author":"TJ McDonald","year":"2013","unstructured":"McDonald TJ, Ellard S. Maturity onset diabetes of the young: identification and diagnosis. Ann Clin Biochem. 2013;50(Pt 5):403\u201315. https:\/\/doi.org\/10.1177\/0004563213483458.","journal-title":"Ann Clin Biochem"},{"issue":"11","key":"716_CR15","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/humu.21110","volume":"30","author":"KK Osbak","year":"2009","unstructured":"Osbak KK, Colclough K, Saint-Martin C, Beer NL, Bellann\u00e9-Chantelot C, Ellard S, Gloyn AL. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia. Hum Mutat. 2009;30(11):1512\u201326. https:\/\/doi.org\/10.1002\/humu.21110.","journal-title":"Hum Mutat"},{"issue":"6","key":"716_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.diabet.2011.04.002","volume":"37","author":"MP Kyithar","year":"2011","unstructured":"Kyithar MP, Bacon S, Pannu KK, Rizvi SR, Colclough K, Ellard S, Byrne MM. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications. Diabetes Metab. 2011;37(6):512\u20139. https:\/\/doi.org\/10.1016\/j.diabet.2011.04.002.","journal-title":"Diabetes Metab"},{"issue":"3","key":"716_CR17","first-page":"139","volume":"149","author":"M Losekoot","year":"2005","unstructured":"Losekoot M, Broekman AJ, Breuning MH, de Koning EJ, Romijn JA, Maassen JA. Moleculaire diagnostiek bij aanwijzingen voor \u201cmaturity onset diabetes of the young\u201d; resultaten bij 184 pati\u00ebnten [Molecular diagnosis on indication of maturity onset diabetes of the young; results from 184 patients]. Ned Tijdschr Geneeskd. 2005;149(3):139\u201343.","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"7","key":"716_CR18","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.2337\/diacare.28.7.1751","volume":"28","author":"A Stride","year":"2005","unstructured":"Stride A, Ellard S, Clark P, Shakespeare L, Salzmann M, Shepherd M, Hattersley AT. Beta-cell dysfunction, insulin sensitivity, and glycosuria precede diabetes in hepatocyte nuclear factor-1alpha mutation carriers. Diabetes Care. 2005;28(7):1751\u20136. https:\/\/doi.org\/10.2337\/diacare.28.7.1751.","journal-title":"Diabetes Care"},{"issue":"1","key":"716_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11154-018-9446-3","volume":"19","author":"RO Yeung","year":"2018","unstructured":"Yeung RO, Hannah-Shmouni F, Niederhoffer K, Walker MA. Not quite type 1 or type 2, what now? Review of monogenic, mitochondrial, and syndromic diabetes. Rev Endocr Metab Disord. 2018;19(1):35\u201352. https:\/\/doi.org\/10.1007\/s11154-018-9446-3.","journal-title":"Rev Endocr Metab Disord"},{"issue":"9","key":"716_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/humu.20357","volume":"27","author":"S Ellard","year":"2006","unstructured":"Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat. 2006;27(9):854\u201369. https:\/\/doi.org\/10.1002\/humu.20357.","journal-title":"Hum Mutat"},{"issue":"4","key":"716_CR21","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1007\/s00125-008-0942-y","volume":"51","author":"S Ellard","year":"2008","unstructured":"Ellard S, Bellann\u00e9-Chantelot C, Hattersley AT, European Molecular Genetics Quality Network (EMQN) MODY group. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008;51(4):546\u201353. https:\/\/doi.org\/10.1007\/s00125-008-0942-y.","journal-title":"Diabetologia"},{"issue":"5","key":"716_CR22","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/humu.22279","volume":"34","author":"K Colclough","year":"2013","unstructured":"Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia. Hum Mutat. 2013;34(5):669\u201385. https:\/\/doi.org\/10.1002\/humu.22279.","journal-title":"Hum Mutat"},{"issue":"10","key":"716_CR23","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1515\/jpem-2020-0093","volume":"33","author":"G Salzano","year":"2020","unstructured":"Salzano G, Passanisi S, Lucanto MC, Costa S, Pajno GB, Lombardo F. GCK-MODY in a child with cystic fibrosis: the doubt of the treatment plan. J Pediatr Endocrinol Metab. 2020;33(10):1359\u201362. https:\/\/doi.org\/10.1515\/jpem-2020-0093.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"716_CR24","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1111\/dme.12992","volume":"33","author":"S Bacon","year":"2016","unstructured":"Bacon S, Kyithar MP, Rizvi SR, Donnelly E, McCarthy A, Burke M, Colclough K, Ellard S, Byrne MM. Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort. Diabet Med. 2016;33(7):976\u201384. https:\/\/doi.org\/10.1111\/dme.12992.","journal-title":"Diabet Med"},{"key":"716_CR25","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2337\/dc19-0486","volume":"42","author":"MS GoodSmith","year":"2019","unstructured":"GoodSmith MS, Skandari MR, Huang ES, Naylor RN. The impact of biomarker screening and cascade genetic testing on the cost-effectiveness of MODY genetic testing. Diabetes Care. 2019;42:2247\u201355. https:\/\/doi.org\/10.2337\/dc19-0486.","journal-title":"Diabetes Care"},{"issue":"12","key":"716_CR26","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2337\/dci20-0065","volume":"43","author":"MC Riddle","year":"2020","unstructured":"Riddle MC, Philipson LH, Rich SS, et al. Monogenic diabetes: From genetic insights to population-based precision in care reflections from a diabetes care editors\u2019 expert forum. Diabetes Care. 2020;43(12):3117. https:\/\/doi.org\/10.2337\/dci20-0065.","journal-title":"Diabetes Care"},{"issue":"6","key":"716_CR27","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1210\/jc.2016-2490","volume":"102","author":"M Delvecchio","year":"2017","unstructured":"Delvecchio M, Mozzillo E, Salzano G, et al. Monogenic diabetes accounts for 6.3% of cases referred to 15 Italian pediatric diabetes centers during 2007 to 2012. J Clin Endocrinol Metab. 2017;102(6):1826\u201334. https:\/\/doi.org\/10.1210\/jc.2016-2490.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"716_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1464-5491.2009.02720.x","volume":"26","author":"E Schober","year":"2009","unstructured":"Schober E, Rami B, Grabert M, et al. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med. 2009;26(5):466\u201373. https:\/\/doi.org\/10.1111\/j.1464-5491.2009.02720.x.","journal-title":"Diabet Med"},{"issue":"4","key":"716_CR29","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000303141","volume":"74","author":"A Galler","year":"2010","unstructured":"Galler A, Stange T, M\u00fcller G, et al. Incidence of childhood diabetes in children aged less than 15 years and its clinical and metabolic characteristics at the time of diagnosis: data from the Childhood Diabetes Registry of Saxony. Germany Horm Res Paediatr. 2010;74(4):285\u201391. https:\/\/doi.org\/10.1159\/000303141.","journal-title":"Germany Horm Res Paediatr"},{"issue":"1","key":"716_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/pedi.12766","volume":"20","author":"SR Johnson","year":"2019","unstructured":"Johnson SR, Ellis JJ, Leo PJ, et al. Comprehensive genetic screening: The prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort. Pediatr Diabetes. 2019;20(1):57\u201364. https:\/\/doi.org\/10.1111\/pedi.12766.","journal-title":"Pediatr Diabetes"},{"issue":"1","key":"716_CR31","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2337\/dc19-0747","volume":"43","author":"A Carlsson","year":"2020","unstructured":"Carlsson A, Shepherd M, Ellard S, et al. Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish national cohort study. Diabetes Care. 2020;43(1):82\u20139. https:\/\/doi.org\/10.2337\/dc19-0747.","journal-title":"Diabetes Care"},{"issue":"11","key":"716_CR32","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.2337\/dc16-0645","volume":"39","author":"M Shepherd","year":"2016","unstructured":"Shepherd M, Shields B, Hammersley S, et al. Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the U.K. pediatric diabetes population with monogenic diabetes. Diabetes Care. 2016;39(11):1879\u201388. https:\/\/doi.org\/10.2337\/dc16-0645.","journal-title":"Diabetes Care"},{"issue":"3","key":"716_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/pedi.12609","volume":"19","author":"JM Sosenko","year":"2018","unstructured":"Sosenko JM, Geyer S, Skyler JS, et al. The influence of body mass index and age on C-peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial-type 1. Pediatr Diabetes. 2018;19(3):403\u20139. https:\/\/doi.org\/10.1111\/pedi.12609.","journal-title":"Pediatr Diabetes"},{"issue":"9","key":"716_CR34","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.2337\/dc19-2547","volume":"43","author":"K Vehik","year":"2020","unstructured":"Vehik K, Bonifacio E, Lernmark \u00c5, et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY Study. Diabetes Care. 2020;43(9):2066\u201373. https:\/\/doi.org\/10.2337\/dc19-2547.","journal-title":"Diabetes Care"},{"issue":"9","key":"716_CR35","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/j.1464-5491.2011.03287.x","volume":"28","author":"TJ McDonald","year":"2011","unstructured":"McDonald TJ, Colclough K, Brown R, Shields B, Shepherd M, Bingley P, Williams A, Hattersley AT, Ellard S. Islet autoantibodies can discriminate maturity-onset diabetes of the young (MODY) from Type 1 diabetes. Diabet Med. 2011;28(9):1028\u201333. https:\/\/doi.org\/10.1111\/j.1464-5491.2011.03287.x.","journal-title":"Diabet Med"},{"issue":"1","key":"716_CR36","doi-asserted-by":"publisher","first-page":"e0169389","DOI":"10.1371\/journal.pone.0169389","volume":"12","author":"I Urrutia","year":"2017","unstructured":"Urrutia I, Mart\u00ednez R, L\u00f3pez-Euba T, Velayos T, Mart\u00ednez-de-LaPiscina I, Bilbao JR, Rica I, Casta\u00f1o L, Spanish Group for the Study of MODY and Type 1 diabetes. Lower frequency of HLA-DRB1 type 1 diabetes risk alleles in pediatric patients with MODY. PLoS ONE. 2017;12(1):e0169389. https:\/\/doi.org\/10.1371\/journal.pone.0169389.","journal-title":"PLoS ONE"},{"issue":"12","key":"716_CR37","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1007\/s001250051101","volume":"41","author":"AM M\u00f8ller","year":"1998","unstructured":"M\u00f8ller AM, Dalgaard LT, Pociot F, Nerup J, Hansen T, Pedersen O. Mutations in the hepatocyte nuclear factor-1alpha gene in Caucasian families originally classified as having Type I diabetes. Diabetologia. 1998;41(12):1528\u201331. https:\/\/doi.org\/10.1007\/s001250051101.","journal-title":"Diabetologia"},{"issue":"2","key":"716_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/1753-0407.13097","volume":"13","author":"M Karaoglan","year":"2021","unstructured":"Karaoglan M, Nacarkahya G. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. J Diabetes. 2021;13(2):154\u201363. https:\/\/doi.org\/10.1111\/1753-0407.13097.","journal-title":"J Diabetes"},{"issue":"9","key":"716_CR39","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00592-018-1179-y","volume":"55","author":"M Delvecchio","year":"2018","unstructured":"Delvecchio M, Salzano G, Bonura C, et al. Can HbA1c combined with fasting plasma glucose help to assess priority for GCK-MODY vs HNF1A-MODY genetic testing? Acta Diabetol. 2018;55(9):981\u20133. https:\/\/doi.org\/10.1007\/s00592-018-1179-y.","journal-title":"Acta Diabetol"},{"issue":"6","key":"716_CR40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/gim.2017.150","volume":"20","author":"JW Kleinberger","year":"2018","unstructured":"Kleinberger JW, Copeland KC, Gandica RG, et al. Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med. 2018;20(6):583\u201390. https:\/\/doi.org\/10.1038\/gim.2017.150.","journal-title":"Genet Med"},{"issue":"7","key":"716_CR41","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1007\/s001250100530","volume":"44","author":"O Massa","year":"2001","unstructured":"Massa O, Meschi F, Cuesta-Munoz A, et al. High prevalence of glucokinase mutations in Italian children with MODY. Influence on glucose tolerance, first-phase insulin response, insulin sensitivity and BMI. Diabetologia. 2001;44(7):898\u2013905. https:\/\/doi.org\/10.1007\/s001250100530.","journal-title":"Diabetologia"},{"issue":"3","key":"716_CR42","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00125-001-0770-9","volume":"45","author":"A Stride","year":"2002","unstructured":"Stride A, Vaxillaire M, Tuomi T, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load. Diabetologia. 2002;45(3):427\u201335. https:\/\/doi.org\/10.1007\/s00125-001-0770-9.","journal-title":"Diabetologia"},{"issue":"5","key":"716_CR43","doi-asserted-by":"publisher","first-page":"E5","DOI":"10.1002\/ppul.24746","volume":"55","author":"M Hang\u00fcl","year":"2020","unstructured":"Hang\u00fcl M, Erdo\u011fan M, Hatipo\u011flu N, K\u00f6se M. Maturity-onset diabetes of the young: Different diabetes in an infant with cystic fibrosis. Pediatr Pulmonol. 2020;55(5):E5\u20137. https:\/\/doi.org\/10.1002\/ppul.24746.","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"716_CR44","doi-asserted-by":"publisher","first-page":"bvaa165","DOI":"10.1210\/jendso\/bvaa165","volume":"5","author":"KJ Scully","year":"2020","unstructured":"Scully KJ, Sawicki G, Kremen J, Putman MS. Monogenic diabetes in a child with cystic fibrosis: a case report and review of the literature. J Endocr Soc. 2020;5(1):bvaa165. https:\/\/doi.org\/10.1210\/jendso\/bvaa165.","journal-title":"J Endocr Soc."},{"key":"716_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.673539","author":"E Mozzillo","year":"2021","unstructured":"Mozzillo E, Franceschi R, Piona C, et al. Diabetes and prediabetes in children with cystic fibrosis: a systematic review of the literature and recommendations of the Italian society for pediatric endocrinology and diabetes (ISPED). Front Endocrinol (Lausanne). 2021. https:\/\/doi.org\/10.3389\/fendo.2021.673539.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"716_CR46","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.2337\/diabetes.54.11.3126","volume":"54","author":"C Bellann\u00e9-Chantelot","year":"2005","unstructured":"Bellann\u00e9-Chantelot C, Clauin S, Chauveau D, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54(11):3126\u201332. https:\/\/doi.org\/10.2337\/diabetes.54.11.3126.","journal-title":"Diabetes"},{"issue":"3","key":"716_CR47","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1111\/pedi.12985","volume":"21","author":"A Xu","year":"2020","unstructured":"Xu A, Lin Y, Sheng H, et al. Molecular diagnosis of maturity-onset diabetes of the young in a cohort of Chinese children. Pediatr Diabetes. 2020;21(3):431\u201340. https:\/\/doi.org\/10.1111\/pedi.12985.","journal-title":"Pediatr Diabetes"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-021-00716-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-021-00716-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T08:18:51Z","timestamp":1631089131000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-021-00716-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,8]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["716"],"URL":"https:\/\/doi.org\/10.1186\/s13098-021-00716-6","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,8]]},"assertion":[{"value":"18 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval: The study protocol was approved by the (local) Ethics Committee of the Medical University of Messina. The study was conducted in accordance with the Declaration of Helsinki.Consent to participate: All participants and their parents or legal guardians provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reviewed the content of this manuscript and provided consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Additional declarations for articles in life science journals that report the results of studies involving humans and\/or animals"}},{"value":"The authors declare that they have no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}